Sklerosierende Hauterkrankungen

Zurück zum Zitat Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L (2017) Cutaneous manifestations of scleroderma and Scleroderma-like disorders: a comprehensive review. Clin Rev Allergy Immunol 53:306–336CrossRef Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L (2017) Cutaneous manifestations of scleroderma and Scleroderma-like disorders: a comprehensive review. Clin Rev Allergy Immunol 53:306–336CrossRef

Zurück zum Zitat Jendrek ST, Kahle B, Riemekasten G (2019) Mimetics of systemic sclerosis. Z Rheumatol 78:14–23CrossRef Jendrek ST, Kahle B, Riemekasten G (2019) Mimetics of systemic sclerosis. Z Rheumatol 78:14–23CrossRef

Zurück zum Zitat Pearson DR, Werth VP, Pappas-Taffer L (2018) Systemic sclerosis: current concepts of skin and systemic manifestations. Clin Dermatol 36:459–474CrossRef Pearson DR, Werth VP, Pappas-Taffer L (2018) Systemic sclerosis: current concepts of skin and systemic manifestations. Clin Dermatol 36:459–474CrossRef

Zurück zum Zitat Sticherling M (2012) Systemic sclerosis—focus on dermatological aspects. Part 2:diagnostics, therapy. J Dtsch Dermatol Ges 10:783–791PubMed Sticherling M (2012) Systemic sclerosis—focus on dermatological aspects. Part 2:diagnostics, therapy. J Dtsch Dermatol Ges 10:783–791PubMed

Zurück zum Zitat Sticherling M (2012) Systemic sclerosis-dermatological aspects. Part 1:Pathogenesis, epidemiology, clinical findings. J Dtsch Dermatol Ges 10:705–718 (quiz 716)PubMed Sticherling M (2012) Systemic sclerosis-dermatological aspects. Part 1:Pathogenesis, epidemiology, clinical findings. J Dtsch Dermatol Ges 10:705–718 (quiz 716)PubMed

Zurück zum Zitat Kucharz EJ, Kopeć-Mędrek M (2017) Systemic sclerosis sine scleroderma. Adv Clin Exp Med 26:875–880CrossRef Kucharz EJ, Kopeć-Mędrek M (2017) Systemic sclerosis sine scleroderma. Adv Clin Exp Med 26:875–880CrossRef

Zurück zum Zitat Knobler R, Moinzadeh P, Hunzelmann N et al (2017) European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol 31:1401–1424CrossRef Knobler R, Moinzadeh P, Hunzelmann N et al (2017) European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol 31:1401–1424CrossRef

Zurück zum Zitat Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. FASEB J 18:816–827CrossRef Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. FASEB J 18:816–827CrossRef

Zurück zum Zitat Distler O, Cozzio A (2016) Systemic sclerosis and localized scleroderma—current concepts and novel targets for therapy. Semin Immunopathol 38:87–95CrossRef Distler O, Cozzio A (2016) Systemic sclerosis and localized scleroderma—current concepts and novel targets for therapy. Semin Immunopathol 38:87–95CrossRef

Zurück zum Zitat Sticherling M (2019) Systemische Sklerodermie – die dermatologische Sicht (Systemic scleroderma – the dermatological view). J Dtsch Dermatol Ges. 2019 (in press) Sticherling M (2019) Systemische Sklerodermie – die dermatologische Sicht (Systemic scleroderma – the dermatological view). J Dtsch Dermatol Ges. 2019 (in press)

Zurück zum Zitat Tartar DM, Chung L, Fiorentino DF (2018) Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis. Clin Dermatol 36:508–524CrossRef Tartar DM, Chung L, Fiorentino DF (2018) Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis. Clin Dermatol 36:508–524CrossRef

Zurück zum Zitat Volkmann ER, Varga J (2019) Emerging targets of disease-modifying therapy for systemic sclerosis. Nat Rev Rheumatol 15:208–224CrossRef Volkmann ER, Varga J (2019) Emerging targets of disease-modifying therapy for systemic sclerosis. Nat Rev Rheumatol 15:208–224CrossRef

Zurück zum Zitat Riemekasten G (2019) Progress in systemic sclerosis—early, targeted and intensive therapy is the key to success. Dtsch Med Wochenschr 144:189–193CrossRef Riemekasten G (2019) Progress in systemic sclerosis—early, targeted and intensive therapy is the key to success. Dtsch Med Wochenschr 144:189–193CrossRef

Zurück zum Zitat Hunzelmann N (2018) Current treatment of systemic scleroderma. Hautarzt 69:901–907CrossRef Hunzelmann N (2018) Current treatment of systemic scleroderma. Hautarzt 69:901–907CrossRef

Zurück zum Zitat Orlandi M, Barsotti S, Lepri G, Codullo V, Di Battista M, Guiducci S, Rossa DA (2018) One year in review 2018: systemic sclerosis. Clin Exp Rheumatol 36(Suppl 113):3–23PubMed Orlandi M, Barsotti S, Lepri G, Codullo V, Di Battista M, Guiducci S, Rossa DA (2018) One year in review 2018: systemic sclerosis. Clin Exp Rheumatol 36(Suppl 113):3–23PubMed

Zurück zum Zitat Kreuter A, Krieg T, Worm M et al (2009) AWMF Guideline no. 013/066. Diagnosis and therapy of circumscribed scleroderma. J Dtsch Dermatol Ges 7(Suppl 6):1–14 Kreuter A, Krieg T, Worm M et al (2009) AWMF Guideline no. 013/066. Diagnosis and therapy of circumscribed scleroderma. J Dtsch Dermatol Ges 7(Suppl 6):1–14

Zurück zum Zitat Fett N, Werth VP (2011) Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 64:217–228CrossRef Fett N, Werth VP (2011) Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 64:217–228CrossRef

Zurück zum Zitat Takehara K, Sato S (2005) Localized scleroderma is an autoimmune disorder. Baillieres Clin Rheumatol 44:274–279 Takehara K, Sato S (2005) Localized scleroderma is an autoimmune disorder. Baillieres Clin Rheumatol 44:274–279

Zurück zum Zitat Mertens JS, Seyger MMB, Thurlings RM, Radstake TRDJ, de Jong EMGJ (2017) Morphea and eosinophilic fasciitis: an update. Am J Clin Dermatol 18:491–512CrossRef Mertens JS, Seyger MMB, Thurlings RM, Radstake TRDJ, de Jong EMGJ (2017) Morphea and eosinophilic fasciitis: an update. Am J Clin Dermatol 18:491–512CrossRef

Zurück zum Zitat Das J, Chinoy H, Dick J, Matthews R, Roberts M (2017) A literature review of eosinophilic fasciitis with an illustrative case. Curr Rheumatol Rev 13:113–120CrossRef Das J, Chinoy H, Dick J, Matthews R, Roberts M (2017) A literature review of eosinophilic fasciitis with an illustrative case. Curr Rheumatol Rev 13:113–120CrossRef

Zurück zum Zitat Ihn H (2019) Eosinophilic fasciitis: From pathophysiology to treatment. Allergol Int. https://doi.org/10.1016/j.alit.2019.03.001 CrossRefPubMed Ihn H (2019) Eosinophilic fasciitis: From pathophysiology to treatment. Allergol Int. https://​doi.​org/​10.​1016/​j.​alit.​2019.​03.​001 CrossRefPubMed

Zurück zum Zitat Mazori DR, Femia AN, Vleugels RA (2017) Eosinophilic fasciitis: an updated review on diagnosis and treatment. Curr Rheumatol Rep 19:74CrossRef Mazori DR, Femia AN, Vleugels RA (2017) Eosinophilic fasciitis: an updated review on diagnosis and treatment. Curr Rheumatol Rep 19:74CrossRef

Zurück zum Zitat Sène D (2015) Eosinophilic fasciitis (Shulman’s disease): diagnostic and therapeutic review. Rev Med Interne 36:738–745CrossRef Sène D (2015) Eosinophilic fasciitis (Shulman’s disease): diagnostic and therapeutic review. Rev Med Interne 36:738–745CrossRef

Zurück zum Zitat Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kähäri V, Kárpáti S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkötter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T (2017) European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis. J Eur Acad Dermatol Venereol 31:1581–1594CrossRef Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kähäri V, Kárpáti S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkötter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T (2017) European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis. J Eur Acad Dermatol Venereol 31:1581–1594CrossRef

Zurück zum Zitat Kreuter A (2018) Scleredema adultorum: Clinical presentation, diagnostic workup, differential diagnosis, treatment option. Hautarzt 69:908–915CrossRef Kreuter A (2018) Scleredema adultorum: Clinical presentation, diagnostic workup, differential diagnosis, treatment option. Hautarzt 69:908–915CrossRef

Zurück zum Zitat Beers WH, Ince A, Moore TL (2006) Scleredema adultorum of Buschke: a case report and review of the literature. Semin Arthritis Rheum 35:355–359CrossRef Beers WH, Ince A, Moore TL (2006) Scleredema adultorum of Buschke: a case report and review of the literature. Semin Arthritis Rheum 35:355–359CrossRef

Zurück zum Zitat Miguel D, Schliemann S, Elsner P (2018) Treatment of scleroedema Adultorum Buschke: a systematic review. Acta Derm Venereol 98:305–309CrossRef Miguel D, Schliemann S, Elsner P (2018) Treatment of scleroedema Adultorum Buschke: a systematic review. Acta Derm Venereol 98:305–309CrossRef

Zurück zum Zitat Kirchberger MC, Sticherling M, Erdmann M (2017) Uncommon presentation of scleromyxoedema with a distribution pattern mimicking a photodermatosis. Acta Derm Venereol 97:979–980CrossRef Kirchberger MC, Sticherling M, Erdmann M (2017) Uncommon presentation of scleromyxoedema with a distribution pattern mimicking a photodermatosis. Acta Derm Venereol 97:979–980CrossRef

Zurück zum Zitat Neufeld M, Sunderkötter C, Moritz RKC (2018) Scleromyxedema. Hautarzt 69:916–921CrossRef Neufeld M, Sunderkötter C, Moritz RKC (2018) Scleromyxedema. Hautarzt 69:916–921CrossRef

Zurück zum Zitat Raczeck P, Fries P, Bücker A, Schneider G (2019) Gadolinium deposition-“gadolinium deposition disease”. Radiologe 59:435–443CrossRef Raczeck P, Fries P, Bücker A, Schneider G (2019) Gadolinium deposition-“gadolinium deposition disease”. Radiologe 59:435–443CrossRef